| http://dbpedia.org/ontology/abstract
|
Plexxikon is an American drug discovery co … Plexxikon is an American drug discovery company based in South San Francisco, California. It was co-founded in 2001 by Joseph Schlessinger of Yale University, and Sung-Hou Kim of the University of California, Berkeley. It uses a proprietary structural biology-based platform called Scaffold-Based Drug Discovery to build a pipeline of products in multiple therapeutic areas. This discovery process integrates multiple technologies, including structural screening as one key component, that it hopes will give a significant competitive advantage over other approaches. In April 2011, Plexxikon was acquired by the Japanese pharmaceutical company Daiichi Sankyo for $805 million and an additional $130 million in potential milestone payments. Daiichi Sankyo announced the shutdown of Plexxikon in 2022.nounced the shutdown of Plexxikon in 2022.
, Plexxikon est une entreprise américaine sp … Plexxikon est une entreprise américaine spécialisée dans la recherche médicale et basée à Berkeley (Californie). Elle est fondée en 2001 par de l'université Yale et de l'université de Californie à Berkeley. En avril 2011, Plexxikon est achetée par l'entreprise pharmaceutique japonaise Daiichi Sankyo pour 805 millions USD et 130 millions de dollars supplémentaires payés par échelonnement.s supplémentaires payés par échelonnement.
|
| http://dbpedia.org/ontology/fate
|
Acquired by theDaiichi Sankyo
|
| http://dbpedia.org/ontology/foundedBy
|
http://dbpedia.org/resource/Joseph_Schlessinger +
|
| http://dbpedia.org/ontology/foundingYear
|
2001
|
| http://dbpedia.org/ontology/headquarter
|
http://dbpedia.org/resource/United_States +
, http://dbpedia.org/resource/California +
, http://dbpedia.org/resource/South_San_Francisco%2C_California +
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/wikiPageID
|
24502945
|
| http://dbpedia.org/ontology/wikiPageLength
|
4614
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1106786872
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/California +
, http://dbpedia.org/resource/Category:American_subsidiaries_of_foreign_companies +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_2001 +
, http://dbpedia.org/resource/United_States +
, http://dbpedia.org/resource/Yale_University +
, http://dbpedia.org/resource/CSF1R +
, http://dbpedia.org/resource/Category:Health_care_companies_based_in_California +
, http://dbpedia.org/resource/Pexidartinib +
, http://dbpedia.org/resource/Sung-Hou_Kim +
, http://dbpedia.org/resource/Joseph_Schlessinger +
, http://dbpedia.org/resource/University_of_California%2C_Berkeley +
, http://dbpedia.org/resource/Daiichi_Sankyo +
, http://dbpedia.org/resource/South_San_Francisco%2C_California +
, http://dbpedia.org/resource/Type_2_diabetes +
, http://dbpedia.org/resource/Category:2001_establishments_in_the_United_States +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Drug_discovery +
, http://dbpedia.org/resource/Vemurafenib +
, http://dbpedia.org/resource/Category:Daiichi_Sankyo +
, http://dbpedia.org/resource/Wyeth_Pharmaceuticals +
|
| http://dbpedia.org/property/fate
|
Acquired by the Daiichi Sankyo
|
| http://dbpedia.org/property/founder
|
http://dbpedia.org/resource/Joseph_Schlessinger +
|
| http://dbpedia.org/property/hqLocation
|
http://dbpedia.org/resource/California +
, http://dbpedia.org/resource/South_San_Francisco%2C_California +
, http://dbpedia.org/resource/United_States +
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/name
|
Plexxikon
|
| http://dbpedia.org/property/type
|
Subsidiary
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:End_date_and_age +
, http://dbpedia.org/resource/Template:Citation_needed +
, http://dbpedia.org/resource/Template:Start_date +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Health_care_companies_based_in_California +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_2001 +
, http://dbpedia.org/resource/Category:Daiichi_Sankyo +
, http://dbpedia.org/resource/Category:American_subsidiaries_of_foreign_companies +
, http://dbpedia.org/resource/Category:2001_establishments_in_the_United_States +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Company +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Plexxikon?oldid=1106786872&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Plexxikon +
|
| http://xmlns.com/foaf/0.1/name
|
Plexxikon
|
| owl:sameAs |
http://dbpedia.org/resource/Plexxikon +
, http://fr.dbpedia.org/resource/Plexxikon +
, https://global.dbpedia.org/id/4tT3X +
, http://rdf.freebase.com/ns/m.0809g3n +
, http://yago-knowledge.org/resource/Plexxikon +
, http://www.wikidata.org/entity/Q7204909 +
|
| rdf:type |
http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/class/yago/Organization108008335 +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/class/yago/WikicatCompaniesEstablishedIn2001 +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.wikidata.org/entity/Q43229 +
, http://schema.org/Organization +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/ontology/Company +
, http://dbpedia.org/class/yago/DrugCompany108002578 +
, http://dbpedia.org/class/yago/WikicatPharmaceuticalCompaniesOfTheUnitedStates +
|
| rdfs:comment |
Plexxikon is an American drug discovery co … Plexxikon is an American drug discovery company based in South San Francisco, California. It was co-founded in 2001 by Joseph Schlessinger of Yale University, and Sung-Hou Kim of the University of California, Berkeley. It uses a proprietary structural biology-based platform called Scaffold-Based Drug Discovery to build a pipeline of products in multiple therapeutic areas. This discovery process integrates multiple technologies, including structural screening as one key component, that it hopes will give a significant competitive advantage over other approaches.mpetitive advantage over other approaches.
, Plexxikon est une entreprise américaine sp … Plexxikon est une entreprise américaine spécialisée dans la recherche médicale et basée à Berkeley (Californie). Elle est fondée en 2001 par de l'université Yale et de l'université de Californie à Berkeley. En avril 2011, Plexxikon est achetée par l'entreprise pharmaceutique japonaise Daiichi Sankyo pour 805 millions USD et 130 millions de dollars supplémentaires payés par échelonnement.s supplémentaires payés par échelonnement.
|
| rdfs:label |
Plexxikon
|
